$CTIC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CTI BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CTI BIOPHARMA CORP. Get notifications about new insider transactions in CTI BIOPHARMA CORP for free.
Page: < prev 1 ... 6 7 8 9 10 11 12 13 13 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.36 | 2,000 | 714 | 1,463,959 | 1.5 M to 1.5 M (-0.14 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.36 | 800 | 285 | 1,465,959 | 1.5 M to 1.5 M (-0.05 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.36 | 1,300 | 462 | 1,466,759 | 1.5 M to 1.5 M (-0.09 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.35 | 1,200 | 425 | 1,468,059 | 1.5 M to 1.5 M (-0.08 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.35 | 300 | 105 | 1,469,259 | 1.5 M to 1.5 M (-0.02 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.35 | 2,300 | 803 | 1,469,559 | 1.5 M to 1.5 M (-0.16 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.35 | 2,100 | 731 | 1,471,859 | 1.5 M to 1.5 M (-0.14 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.35 | 1,400 | 486 | 1,473,959 | 1.5 M to 1.5 M (-0.09 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.35 | 2,291 | 793 | 1,475,359 | 1.5 M to 1.5 M (-0.16 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.35 | 4,300 | 1,484 | 1,477,650 | 1.5 M to 1.5 M (-0.29 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.34 | 1,700 | 585 | 1,481,950 | 1.5 M to 1.5 M (-0.11 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.34 | 5,300 | 1,818 | 1,483,650 | 1.5 M to 1.5 M (-0.36 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.34 | 4,400 | 1,505 | 1,488,950 | 1.5 M to 1.5 M (-0.29 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.34 | 5,600 | 1,910 | 1,493,350 | 1.5 M to 1.5 M (-0.37 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.34 | 7,900 | 2,686 | 1,498,950 | 1.5 M to 1.5 M (-0.52 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.34 | 1,100 | 373 | 1,506,850 | 1.5 M to 1.5 M (-0.07 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.34 | 2,362 | 798 | 1,507,950 | 1.5 M to 1.5 M (-0.16 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.34 | 500 | 169 | 1,510,312 | 1.5 M to 1.5 M (-0.03 %) |
May 26 2010 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 0.33 | 300 | 100 | 1,510,812 | 1.5 M to 1.5 M (-0.02 %) |
May 05 2010 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 0.61 | 2,900 | 1,769 | 1,116,306 | 1.1 M to 1.1 M (-0.26 %) |
May 05 2010 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 0.60 | 2,700 | 1,620 | 1,119,206 | 1.1 M to 1.1 M (-0.24 %) |
May 05 2010 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 0.60 | 2,523 | 1,511 | 1,121,906 | 1.1 M to 1.1 M (-0.22 %) |
May 05 2010 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 0.60 | 14,600 | 8,731 | 1,124,429 | 1.1 M to 1.1 M (-1.28 %) |
May 05 2010 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 0.60 | 12,800 | 7,642 | 1,139,029 | 1.2 M to 1.1 M (-1.11 %) |
May 05 2010 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 0.60 | 3,000 | 1,788 | 1,151,829 | 1.2 M to 1.2 M (-0.26 %) |
May 05 2010 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 0.60 | 1,477 | 879 | 1,154,829 | 1.2 M to 1.2 M (-0.13 %) |
Mar 26 2010 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | Chief Medical Offic ... | Payment of Exercise | F | 0.67 | 105,579 | 70,738 | 2,035,000 | 2.1 M to 2 M (-4.93 %) |
Mar 26 2010 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Payment of Exercise | F | 0.67 | 105,579 | 70,738 | 2,026,422 | 2.1 M to 2 M (-4.95 %) |
Mar 26 2010 | CTIC | CTI BIOPHARMA CORP | PHILIPS CRAIG | President | Payment of Exercise | F | 0.67 | 211,158 | 141,476 | 3,328,239 | 3.5 M to 3.3 M (-5.97 %) |
Mar 26 2010 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | CEO | Payment of Exercise | F | 0.67 | 351,931 | 235,794 | 4,206,028 | 4.6 M to 4.2 M (-7.72 %) |
Mar 26 2010 | CTIC | CTI BIOPHARMA CORP | Eramian Daniel G | EVP, Corporate Comm ... | Payment of Exercise | F | 0.67 | 105,579 | 70,738 | 1,684,916 | 1.8 M to 1.7 M (-5.90 %) |
Jan 04 2010 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Sell | D | 0.00 | 6,048 | 0 | 2,140,579 | 2.1 M to 2.1 M (-0.28 %) |
Jan 04 2010 | CTIC | CTI BIOPHARMA CORP | Eramian Daniel G | EVP, Corporate Comm ... | Sell | D | 0.00 | 5,040 | 0 | 1,790,495 | 1.8 M to 1.8 M (-0.28 %) |
Jan 04 2010 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | D | 0.00 | 6,048 | 0 | 2,132,001 | 2.1 M to 2.1 M (-0.28 %) |
Jan 04 2010 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | CEO | Sell | D | 0.00 | 20,162 | 0 | 4,557,959 | 4.6 M to 4.6 M (-0.44 %) |
Dec 30 2009 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Gift | G | 0.00 | 25,000 | 0 | 853,188 | 878.2 K to 853.2 K (-2.85 %) |
Dec 30 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | CEO | Gift | G | 0.00 | 25,000 | 0 | 4,578,121 | 4.6 M to 4.6 M (-0.54 %) |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Option Exercise | A | 0.00 | 660,376 | 0 | 660,376 | |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Option Exercise | A | 0.00 | 440,251 | 0 | 440,251 | |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Option Exercise | A | 0.00 | 440,251 | 0 | 440,251 | |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Option Exercise | A | 0.00 | 440,251 | 0 | 440,251 | |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | Eramian Daniel G | EVP, Corporate Comm ... | Option Exercise | A | 0.00 | 1,320,752 | 0 | 1,320,752 | |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Option Exercise | A | 0.00 | 1,790,353 | 0 | 1,790,353 | |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Option Exercise | A | 0.00 | 440,251 | 0 | 440,251 | |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Option Exercise | A | 0.00 | 1,790,353 | 0 | 1,790,353 | |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Option Exercise | A | 0.00 | 440,251 | 0 | 440,251 | |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | PHILIPS CRAIG | President | Option Exercise | A | 0.00 | 2,641,504 | 0 | 2,641,504 | |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | BAUER JOHN H | Director | Option Exercise | A | 0.00 | 440,251 | 0 | 440,251 | |
Dec 17 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | CEO | Option Exercise | A | 0.00 | 4,402,507 | 0 | 4,402,507 | |
Nov 24 2009 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Grant | A | 0.00 | 653,690 | 0 | 1,511,112 | 857.4 K to 1.5 M (+76.24 %) |
Nov 13 2009 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Grant | A | 0.00 | 290,017 | 0 | 878,188 | 588.2 K to 878.2 K (+49.31 %) |
Nov 13 2009 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Grant | A | 0.00 | 290,017 | 0 | 893,272 | 603.3 K to 893.3 K (+48.08 %) |
Nov 13 2009 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Grant | A | 0.00 | 290,017 | 0 | 857,422 | 567.4 K to 857.4 K (+51.11 %) |
Nov 13 2009 | CTIC | CTI BIOPHARMA CORP | BAUER JOHN H | Director | Grant | A | 0.00 | 290,017 | 0 | 788,147 | 498.1 K to 788.1 K (+58.22 %) |
Nov 13 2009 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Grant | A | 0.00 | 290,017 | 0 | 893,085 | 603.1 K to 893.1 K (+48.09 %) |
Nov 13 2009 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Grant | A | 0.00 | 435,025 | 0 | 1,156,306 | 721.3 K to 1.2 M (+60.31 %) |
Nov 12 2009 | CTIC | CTI BIOPHARMA CORP | Eramian Daniel G | EVP, Corporate Comm ... | Payment of Exercise | F | 0.99 | 317,133 | 313,962 | 1,795,535 | 2.1 M to 1.8 M (-15.01 %) |
Nov 12 2009 | CTIC | CTI BIOPHARMA CORP | Eramian Daniel G | EVP, Corporate Comm ... | Grant | A | 0.00 | 870,050 | 0 | 2,112,668 | 1.2 M to 2.1 M (+70.02 %) |
Nov 12 2009 | CTIC | CTI BIOPHARMA CORP | PHILIPS CRAIG | President | Payment of Exercise | F | 0.99 | 634,266 | 627,923 | 3,539,397 | 4.2 M to 3.5 M (-15.20 %) |
Nov 12 2009 | CTIC | CTI BIOPHARMA CORP | PHILIPS CRAIG | President | Grant | A | 0.00 | 1,740,101 | 0 | 4,173,663 | 2.4 M to 4.2 M (+71.50 %) |
Nov 12 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | CEO | Payment of Exercise | F | 0.99 | 1,057,111 | 1,046,540 | 4,603,121 | 5.7 M to 4.6 M (-18.68 %) |
Nov 12 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | CEO | Grant | A | 0.00 | 2,900,168 | 0 | 5,660,232 | 2.8 M to 5.7 M (+105.08 %) |
Nov 12 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Payment of Exercise | F | 0.99 | 429,187 | 424,895 | 2,138,049 | 2.6 M to 2.1 M (-16.72 %) |
Nov 12 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Grant | A | 0.00 | 1,177,468 | 0 | 2,567,236 | 1.4 M to 2.6 M (+84.72 %) |
Nov 12 2009 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Payment of Exercise | F | 0.99 | 429,187 | 424,895 | 2,146,627 | 2.6 M to 2.1 M (-16.66 %) |
Nov 12 2009 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Grant | A | 0.00 | 1,177,468 | 0 | 2,575,814 | 1.4 M to 2.6 M (+84.20 %) |
Oct 23 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | CEO | Payment of Exercise | F | 1.11 | 54,675 | 60,689 | 2,760,064 | 2.8 M to 2.8 M (-1.94 %) |
Oct 23 2009 | CTIC | CTI BIOPHARMA CORP | PHILIPS CRAIG | President | Payment of Exercise | F | 1.11 | 27,337 | 30,344 | 2,433,562 | 2.5 M to 2.4 M (-1.11 %) |
Oct 23 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Payment of Exercise | F | 1.11 | 27,337 | 30,344 | 1,389,768 | 1.4 M to 1.4 M (-1.93 %) |
Oct 23 2009 | CTIC | CTI BIOPHARMA CORP | Eramian Daniel G | EVP, Corporate Comm ... | Payment of Exercise | F | 1.11 | 27,337 | 30,344 | 1,242,618 | 1.3 M to 1.2 M (-2.15 %) |
Oct 23 2009 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Payment of Exercise | F | 1.11 | 27,337 | 30,344 | 1,398,346 | 1.4 M to 1.4 M (-1.92 %) |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Option Exercise | A | 1.07 | 30,000 | 32,100 | 30,000 | |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Grant | A | 0.00 | 20,000 | 0 | 603,068 | 583.1 K to 603.1 K (+3.43 %) |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Option Exercise | A | 1.07 | 30,000 | 32,100 | 30,000 | |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Grant | A | 0.00 | 20,000 | 0 | 721,281 | 701.3 K to 721.3 K (+2.85 %) |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Option Exercise | A | 1.07 | 30,000 | 32,100 | 30,000 | |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Grant | A | 0.00 | 20,000 | 0 | 588,171 | 568.2 K to 588.2 K (+3.52 %) |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Option Exercise | A | 1.07 | 30,000 | 32,100 | 30,000 | |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Grant | A | 0.00 | 20,000 | 0 | 603,255 | 583.3 K to 603.3 K (+3.43 %) |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Option Exercise | A | 1.07 | 30,000 | 32,100 | 30,000 | |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Grant | A | 0.00 | 20,000 | 0 | 567,405 | 547.4 K to 567.4 K (+3.65 %) |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | BAUER JOHN H | Director | Option Exercise | A | 1.07 | 30,000 | 32,100 | 30,000 | |
Oct 21 2009 | CTIC | CTI BIOPHARMA CORP | BAUER JOHN H | Director | Grant | A | 0.00 | 20,000 | 0 | 498,130 | 478.1 K to 498.1 K (+4.18 %) |
Sep 25 2009 | CTIC | CTI BIOPHARMA CORP | PHILIPS CRAIG | President | Sell | S | 1.24 | 211,500 | 262,450 | 2,460,899 | 2.7 M to 2.5 M (-7.91 %) |
Sep 25 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.23 | 100,380 | 123,467 | 1,417,105 | 1.5 M to 1.4 M (-6.61 %) |
Sep 25 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.23 | 100 | 123 | 1,517,485 | 1.5 M to 1.5 M (-0.01 %) |
Sep 25 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.24 | 5,100 | 6,299 | 1,517,585 | 1.5 M to 1.5 M (-0.33 %) |
Sep 25 2009 | CTIC | CTI BIOPHARMA CORP | Eramian Daniel G | EVP, Corporate Comm ... | Sell | S | 1.25 | 104,276 | 130,345 | 1,269,955 | 1.4 M to 1.3 M (-7.59 %) |
Sep 25 2009 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Sell | S | 1.23 | 96,380 | 118,547 | 1,425,683 | 1.5 M to 1.4 M (-6.33 %) |
Sep 25 2009 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Sell | S | 1.24 | 5,000 | 6,175 | 1,522,063 | 1.5 M to 1.5 M (-0.33 %) |
Sep 25 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | CEO | Sell | S | 1.19 | 318,621 | 379,733 | 2,814,739 | 3.1 M to 2.8 M (-10.17 %) |
Sep 11 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | CEO | Sell | S | 1.43 | 1,366,108 | 1,953,534 | 3,133,360 | 4.5 M to 3.1 M (-30.36 %) |
Aug 14 2009 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 1.57 | 164,000 | 257,480 | 701,281 | 865.3 K to 701.3 K (-18.95 %) |
Aug 13 2009 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 1.64 | 70,000 | 114,800 | 547,405 | 617.4 K to 547.4 K (-11.34 %) |
Aug 11 2009 | CTIC | CTI BIOPHARMA CORP | BAUER JOHN H | Director | Sell | S | 1.50 | 80,000 | 120,000 | 478,130 | 558.1 K to 478.1 K (-14.33 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | Eramian Daniel G | EVP, Corporate Comm ... | Payment of Exercise | F | 1.48 | 235,064 | 347,895 | 964,398 | 1.2 M to 964.4 K (-19.60 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | Eramian Daniel G | EVP, Corporate Comm ... | Grant | A | 0.00 | 644,897 | 0 | 1,609,295 | 964.4 K to 1.6 M (+66.87 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Payment of Exercise | F | 1.48 | 319,295 | 472,557 | 1,527,063 | 1.8 M to 1.5 M (-17.29 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Grant | A | 0.00 | 875,981 | 0 | 1,846,358 | 970.4 K to 1.8 M (+90.27 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Grant | A | 0.00 | 214,966 | 0 | 583,068 | 368.1 K to 583.1 K (+58.40 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Grant | A | 0.00 | 322,449 | 0 | 865,281 | 542.8 K to 865.3 K (+59.40 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | PHILIPS CRAIG | President | Payment of Exercise | F | 1.48 | 470,130 | 695,792 | 2,672,399 | 3.1 M to 2.7 M (-14.96 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | PHILIPS CRAIG | President | Grant | A | 0.00 | 1,289,795 | 0 | 3,142,529 | 1.9 M to 3.1 M (+69.62 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Grant | A | 0.00 | 214,966 | 0 | 568,171 | 353.2 K to 568.2 K (+60.86 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Grant | A | 0.00 | 214,966 | 0 | 617,405 | 402.4 K to 617.4 K (+53.42 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Payment of Exercise | F | 1.48 | 319,295 | 472,557 | 1,522,685 | 1.8 M to 1.5 M (-17.33 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Grant | A | 0.00 | 875,981 | 0 | 1,841,980 | 966 K to 1.8 M (+90.68 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Grant | A | 0.00 | 214,966 | 0 | 583,255 | 368.3 K to 583.3 K (+58.37 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | CEO | Payment of Exercise | F | 1.48 | 783,550 | 1,159,654 | 4,499,468 | 5.3 M to 4.5 M (-14.83 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | CEO | Grant | A | 0.00 | 2,149,658 | 0 | 5,283,018 | 3.1 M to 5.3 M (+68.61 %) |
Jul 31 2009 | CTIC | CTI BIOPHARMA CORP | BAUER JOHN H | Director | Grant | A | 0.00 | 214,966 | 0 | 558,130 | 343.2 K to 558.1 K (+62.64 %) |
Jun 09 2009 | CTIC | CTI BIOPHARMA CORP | BAUER JOHN H | Director | Sell | S | 1.76 | 25,000 | 44,000 | 343,164 | 368.2 K to 343.2 K (-6.79 %) |
Apr 02 2009 | CTIC | CTI BIOPHARMA CORP | BAUER JOHN H | Director | Grant | A | 0.00 | 321,839 | 0 | 368,164 | 46.3 K to 368.2 K (+694.74 %) |
Apr 02 2009 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Grant | A | 0.00 | 321,839 | 0 | 368,289 | 46.5 K to 368.3 K (+692.87 %) |
Apr 02 2009 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Grant | A | 0.00 | 321,839 | 0 | 402,439 | 80.6 K to 402.4 K (+399.30 %) |
Apr 02 2009 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Grant | A | 0.00 | 482,759 | 0 | 542,832 | 60.1 K to 542.8 K (+803.62 %) |
Apr 02 2009 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Grant | A | 0.00 | 321,839 | 0 | 353,205 | 31.4 K to 353.2 K (+1,026.08 %) |
Apr 02 2009 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Grant | A | 0.00 | 321,839 | 0 | 368,102 | 46.3 K to 368.1 K (+695.67 %) |
Mar 27 2009 | CTIC | CTI BIOPHARMA CORP | Eramian Daniel G | EVP, Corporate Comm ... | Grant | A | 0.00 | 868,967 | 0 | 964,398 | 95.4 K to 964.4 K (+910.57 %) |
Mar 27 2009 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Grant | A | 0.00 | 868,967 | 0 | 970,377 | 101.4 K to 970.4 K (+856.88 %) |
Mar 27 2009 | CTIC | CTI BIOPHARMA CORP | PHILIPS CRAIG | President | Grant | A | 0.00 | 1,737,934 | 0 | 1,852,734 | 114.8 K to 1.9 M (+1,513.88 %) |
Mar 27 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Grant | A | 0.00 | 868,967 | 0 | 965,999 | 97 K to 966 K (+895.55 %) |
Mar 27 2009 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | Chief Executive Off ... | Grant | A | 0.00 | 2,896,557 | 0 | 3,133,360 | 236.8 K to 3.1 M (+1,223.19 %) |
Mar 11 2009 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Sell | S | 2.71 | 35 | 95 | 28,849 | 28.9 K to 28.8 K (-0.12 %) |
Jan 09 2009 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Grant | A | 0.00 | 4,451,513 | 0 | 4,532,113 | 80.6 K to 4.5 M (+5,522.97 %) |
Jan 06 2009 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Sell | S | 0.13 | 1,520 | 192 | 101,445 | 103 K to 101.4 K (-1.48 %) |
Dec 31 2008 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Sell | S | 0.13 | 919 | 115 | 102,965 | 103.9 K to 103 K (-0.88 %) |
Dec 19 2008 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | Chief Executive Off ... | Sell | D | 0.00 | 3,125 | 0 | 236,803 | 239.9 K to 236.8 K (-1.30 %) |
Oct 24 2008 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | Chief Executive Off ... | Grant | A | 0.00 | 150,000 | 0 | 239,928 | 89.9 K to 239.9 K (+166.80 %) |
Oct 24 2008 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Grant | A | 0.00 | 75,000 | 0 | 97,032 | 22 K to 97 K (+340.41 %) |
Oct 24 2008 | CTIC | CTI BIOPHARMA CORP | PHILIPS CRAIG | President | Grant | A | 0.00 | 75,000 | 0 | 114,800 | 39.8 K to 114.8 K (+188.44 %) |
Oct 24 2008 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Medical ... | Grant | A | 0.00 | 75,000 | 0 | 103,884 | 28.9 K to 103.9 K (+259.66 %) |
Oct 24 2008 | CTIC | CTI BIOPHARMA CORP | Eramian Daniel G | EVP, Corporate Comm ... | Grant | A | 0.00 | 75,000 | 0 | 95,431 | 20.4 K to 95.4 K (+367.09 %) |
Oct 24 2008 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Grant | A | 0.00 | 40,000 | 0 | 46,263 | 6.3 K to 46.3 K (+638.67 %) |
Oct 24 2008 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Grant | A | 0.00 | 50,000 | 0 | 60,073 | 10.1 K to 60.1 K (+496.38 %) |
Oct 24 2008 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Grant | A | 0.00 | 25,000 | 0 | 31,366 | 6.4 K to 31.4 K (+392.71 %) |
Oct 24 2008 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Grant | A | 0.00 | 25,000 | 0 | 80,600 | 55.6 K to 80.6 K (+44.96 %) |
Oct 24 2008 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Grant | A | 0.00 | 40,000 | 0 | 46,450 | 6.5 K to 46.5 K (+620.16 %) |
Oct 24 2008 | CTIC | CTI BIOPHARMA CORP | BAUER JOHN H | Director | Grant | A | 0.00 | 40,000 | 0 | 46,325 | 6.3 K to 46.3 K (+632.41 %) |
Jun 23 2008 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Option Exercise | A | 0.51 | 36,000 | 18,360 | 36,000 | |
Jun 23 2008 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Grant | A | 0.00 | 9,000 | 0 | 62,625 | 53.6 K to 62.6 K (+16.78 %) |
Jun 23 2008 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Option Exercise | A | 5.85 | 750 | 4,388 | 3,750 | |
Jun 23 2008 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Option Exercise | A | 0.51 | 36,000 | 18,360 | 36,000 | |
Jun 23 2008 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Grant | A | 0.00 | 9,000 | 0 | 100,726 | 91.7 K to 100.7 K (+9.81 %) |
Jun 23 2008 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Option Exercise | A | 0.51 | 36,000 | 18,360 | 36,000 | |
Jun 23 2008 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Grant | A | 0.00 | 9,000 | 0 | 63,663 | 54.7 K to 63.7 K (+16.46 %) |
Jun 23 2008 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Option Exercise | A | 0.51 | 36,000 | 18,360 | 36,000 | |
Jun 23 2008 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Grant | A | 0.00 | 9,000 | 0 | 555,996 | 547 K to 556 K (+1.65 %) |
Jun 23 2008 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Option Exercise | A | 0.51 | 36,000 | 18,360 | 36,000 | |
Jun 23 2008 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Grant | A | 0.00 | 9,000 | 0 | 64,500 | 55.5 K to 64.5 K (+16.22 %) |